Overview

Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use

Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study examines whether isolated doses of d-cycloserine enhance the efficacy of an exposure-based cognitive-behavioral treatment for chronic and treatment refractory substance dependence.
Phase:
Phase 2
Details
Lead Sponsor:
Boston University
Boston University Charles River Campus
Collaborators:
Massachusetts General Hospital
National Institute on Drug Abuse (NIDA)
Treatments:
Cycloserine